Psound Bytes Pro

Biologic Fulfillment Fundamentals (BFF) Campaign from the NPF, sponsored by Janssen, supports dermatology biologic coordinators working to help psoriasis patients start and stay on their biologic treatment. Hear Joe Holton and Toby Thomas discuss what biologic coordinators and patients need to know about different types of insurance plans and prior authorizations when prescribed a biologic treatment.

For more information, visit psoriasis.org/BFF.

Psoriasis can look different in darker skin types making it a challenge to diagnose. World-renowned dermatologist and expert in skin of color, Dr. Seemal Desai from Innovative Dermatology in Plano, TX, addresses the presentation, diagnosis and treatment of psoriasis in skin of color. Disclosures/credit: https://www.eeds.com/em/2256. This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.

Hear dermatologist Dr. Mark Lebwohl, Mt. Sinai Health System, cardiologist Dr. Nehal Mehta and Dr. Heather Teague from the NIH Section of Inflammation and Cardiometabolic Diseases discuss the effect of systemic psoriasis treatments on CVD, diabetes and psoriatic arthritis. For disclosures/credits: https://www.eeds.com/em/2172. This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB. To access articles mentioned https://bit.ly/2MKjlrB .

COVID-19 Task Force Co-Chairs dermatologist Dr. Joel Gelfand, Psoriasis & Phototherapy Treatment Center at PENN, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center, return to discuss the new vaccines and their use with psoriatic disease treatments. Disclosures/credit: https://www.eeds.com/em/1920. This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.

Perhaps five percent of people with psoriasis experience guttate psoriasis which occurs acutely. Dr. Steven Feldman, Wake Forest School of Medicine in Winston-Salem, NC, discusses characteristics, differential diagnoses, the connection to strep throat and effective treatment options. For disclosures and credit: https://www.eeds.com/em/1865. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.

Meeting the needs of patients with GPP, PPP or PPPP can be challenging. Listen as Dr. Kristina Callis Duffin, Chair, Department of Dermatology at the University of Utah, discusses challenges from evaluation, the IL-36RN gene, triggers, types, current treatment and what's in the pipeline. For disclosures and credit: https://www.eeds.com/em/1784. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.

Listen as dermatologist and rheumatologist Dr. Joseph Merola, Brigham and Women's Hospital in Boston, discusses the complexities of diagnosis, impact, efficacy of treatments and normalization of genital and inverse psoriasis. For disclosures and credit: https://www.eeds.com/em/1756. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.

Inclusion of diversity can impact design, recruitment, informed consent and data in clinical trials. Listen as rheumatologist Dr. Niti Goel, Duke University School of Medicine, Durham, NC, addresses issues tied to diversity and what can be done to improve inclusion in clinical trials. For disclosures and to claim credit go to https://www.eeds.com/em/1732. This program is supported by an unrestricted educational grant from Amgen.

Listen as dermatologist Dr. Elizabeth Prater, Medical Director, Healthy Skin Dermatology in Oklahoma City, addresses the latest guidelines and factors that impact use of topical therapies and alternative medicine modalities. For disclosures and to claim .25 CME credits complete the online post evaluation at cme.psoriasis.org, enduring materials. This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.

Given the pandemic and need for clarity, NPF developed a COVID-19 Task Force. Listen as Co-Chairs, dermatologist Dr. Joel Gelfand, Director, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Co-Director, Psoriasis Center, University of Rochester Medical Center in New York, discuss the evidence and content of NPF's 22 guidance statements addressing effects, risks, and best practices for treatment of patients with psoriatic disease. For disclosures and to claim credit, go to https://www.eeds.com/em/1545.